Search

Glaukos Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

176.65 -1.91

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

176.54

Max

178.85

Pagrindiniai rodikliai

By Trading Economics

Pajamos

1.4M

-18M

Pardavimai

35M

186M

Pelnas, tenkantis vienai akcijai

-0.14

Pelno marža

-9.901

Darbuotojai

1,094

EBITDA

-1.6M

-6.9M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+9.08% upside

Dividendai

By Acuity

Kitas uždarbis

2026-10-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.7B

11B

Ankstesnė atidarymo kaina

178.56

Ankstesnė uždarymo kaina

176.65

Naujienos nuotaikos

By Acuity

50%

50%

134 / 339 reitingas Healthcare

Glaukos Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-01 19:31; UTC

Glaukos Corp. shares are lower today amid broader market volatility and rising U.S. Treasury yields, continuing a three-session decline.

2026-08-31 20:07; UTC

Glaukos Corp shares are lower amid broader market concerns over inflation and potential Fed rate hikes. Earlier, the stock rebounded from a session low.

2026-08-28 20:07; UTC

Glaukos Corp shares are lower during Friday's session amid rising U.S. Treasury yields and broader market trends, with no specific company news identified.

2026-08-27 20:07; UTC

Glaukos Corp. shares are higher amid broader market trends. A decline in initial jobless claims may support a positive outlook for health care stocks.

2026-08-25 20:07; UTC

Glaukos Corp shares are lower today amid broader market declines, despite remaining above their 20-day moving average and near the top of their one-month range.

2026-08-21 19:56; UTC

Glaukos Corp's shares are higher today, reflecting a cumulative gain since Thursday. The stock remains near the upper end of its one-month range.

2026-08-20 20:06; UTC

Glaukos Corp. shares are lower today, reflecting a decline from Wednesday's close. The stock earlier pulled back after reaching a session high.

2026-08-19 20:06; UTC

News

Glaukos Corp will present at the Wells Fargo Healthcare Conference on September 9, 2026, as shares gain during Wednesday's trading session.

2026-08-14 19:46; UTC

Glaukos Corp. shares are lower today, reaching a session low amid broader market declines following a surprise drop in U.S. retail sales for July.

2026-08-13 19:22; UTC

Glaukos Corp. shares are higher today amid unusually high trading volume. The stock remains significantly above its 20-day moving average.

2026-08-12 19:16; UTC

Glaukos Corp shares are higher today, supported by overall strength in U.S. stocks and positive quarterly results from AI sector companies.

2026-08-10 20:06; UTC

Glaukos Corp shares are higher today, following a broader market trend since Friday. Earlier, the stock reached a session high before pulling back.

2026-08-07 20:02; UTC

Glaukos Corp shares are rising in Friday's session, supported by unusually high trading volume and a steady upward trend since Thursday's close.

2026-08-04 19:36; UTC

Glaukos Corp shares are lower today, impacted by declines in the Health Care Equipment sub-sector. The stock pulled back after reaching an earlier high.

2026-08-03 20:06; UTC

Glaukos Corp shares are higher amid positive market sentiment, with the S&P 500 and Nasdaq 100 also gaining. The stock remains above its 20-day moving average.

2026-07-31 19:45; UTC

News

Glaukos shares are lower today despite H.C. Wainwright raising the price target to $195 from $168. Trading volume has been unusually high.

2026-07-30 21:31; UTC

News

Glaukos Corp shares are lower in after-market trading, tracking declines in the Health Care Equipment sector. UBS raised its price target to $172.

2026-07-29 21:22; UTC

Social Media
News

Glaukos Corp reported record net sales of $185.6 million in Q2 2026, raising its full-year revenue guidance to $680 million to $700 million. Shares are higher in after-market trading.

2026-07-28 17:46; UTC

News

Glaukos Corp shares are lower after UBS initiated coverage with a Neutral rating, overshadowing Stifel's Buy rating and $175 price target.

2026-07-27 19:16; UTC

Glaukos Corp shares are lower today, despite an initial gain. Broader market trends are affected by a significant drop in oil prices.

2026-07-24 19:56; UTC

Glaukos Corp. shares are trading higher today, maintaining a cumulative gain since Thursday and remaining above their 20-day moving average.

2026-07-21 17:41; UTC

Glaukos Corp shares are lower today amid a decline in the Health Care Equipment sub-sector, reversing the recent trend of higher daily closes.

Akcijų palyginimas

Kainos pokytis

Glaukos Corp Prognozė

Kainos tikslas

By TipRanks

9.08% į viršų

12 mėnesių prognozė

Vidutinis 193.58 USD  9.08%

Aukščiausias 225 USD

Žemiausias 165 USD

Remiantis 13 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Glaukos Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

13 ratings

12

Pirkti

1

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

134 / 339 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
help-icon Live chat